Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

ERSP habla Español

This article was originally published in The Tan Sheet

Executive Summary

Claims for "The System Tratamiento Contra La Obsedidad" Centro Natural De Salud's weight-loss system, are the subject of the first Spanish language infomercial addressed by the Electronic Retailing Self-Regulation Program. The review follows FTC's 2004 launch of an "ongoing and comprehensive campaign" to stop fraudulent advertising to Spanish-speaking consumers (1"The Tan Sheet" June 21, 2004, p. 11). ERSP deems the marketer's evidence insufficient support of its weight-loss claims such as "everything you lose, you will never gain back, guaranteed," as well as specific product claims and customer testimonials. The company agreed to modify all advertising as suggested...

You may also be interested in...



Hispanic Weight-Loss Supplement Marketer Target Of New FTC Initiative

Weight-loss supplements promoted to the Hispanic community have been enjoined from making egregious claims pursuant to a stipulated final order in U.S. District Court in Southern Florida

Lack Of Industry Involvement In Scoping Process Exacerbates ‘Unworkable’ Timelines

Scientific advice could help companies make up for the lack of involvement in scoping, but slots are in short supply.

Cosmetic And Personal Care Trademark Review: 16 April

Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS098033

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel